ACC/AHA release updated guidelines for dyslipidemia management

The American College of Cardiology and American Heart Association have issued new 2026 guidelines for dyslipidemia management. These updates incorporate PREVENT equations to assess cardiovascular disease risk and introduce a 'Calculate-Personalize-Reclassify and Reassess' method, allowing coronary artery calcium testing to refine statin therapy decisions for patients at borderline or intermediate risk. This aims to improve personalized risk assessment and treatment strategies for heart health.